Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.

@article{Peng2012HepatitisBV,
  title={Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.},
  author={Jie-wen Peng and Gui-Nan Lin and Jian-jun Xiao and Xiao-mei Jiang},
  journal={Asia-Pacific journal of clinical oncology},
  year={2012},
  volume={8 4},
  pages={356-61}
}
AIM The effect of transcatheter arterial chemoembolization (TACE) therapy on hepatitis B virus (HBV) reactivation in hepatocellular carcinoma (HCC) patients with prior resolved hepatitis B is not fully understood. METHODS From January 2006 to December 2010, 43 hepatitis B surface antigen (HBsAg)-negative/anti-hepatitis B core antigen (HBc) positive patients with newly diagnosed unresectable HCC were enrolled in the study. All underwent TACE therapy. RESULTS Four patients (9.3%) developed… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 14 references

Reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab

W Yeo, TC Chan, Leung NWY
J Clin Oncol • 2009

Risk of hepatitis

JW Park, KW Park, SH Cho
2009

A randomized controlled

JW Jang, JY Choi, SH Bae
Gastroenterol • 2005

Similar Papers

Loading similar papers…